Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Conditions: Lung Atypical Carcinoid Tumor; Lung Typical Carcinoid Tumor; Metastatic Digestive System Neuroendocrine Neoplasm; Metastatic Lung Neuroendocrine Neoplasm; Metastatic Pancreatic Neuroendocrine Tumor; Survivin Positive Interventions: Biological: Incomplete Freund's Adjuvant; Drug: Octreotide Acetate; Biological: Sargramostim; Biological: SVN53-67/M57-KLH Peptide Vaccine Sponsors: Roswell Park Cancer Institute; NeuroEndocrine Tumor Research Foundation (NETRF); National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials